Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3

Article English OPEN
Vicari, Enzo; Vignera, La Sandro; Castiglione, Roberto; Condorelli, Rosita A; Vicari, Lucia O; Calogero, Aldo E;
  • Publisher: Wolters Kluwer Medknow Publications
  • Journal: Asian Journal of Andrology, volume 16, issue 5, pages 735-739 (issn: 1008-682X, eissn: 1745-7262)
  • Publisher copyright policies & self-archiving
  • Identifiers: pmc: PMC4215680, doi: 10.4103/1008-682X.131064
  • Subject: chronic bacterial prostatitis; irritable bowel syndrome; probiotic VSL#3; prostate-vesiculitis; prostate-vesiculo-epididymitis; rifaximin | Original Article | Diseases of the genitourinary system. Urology | RC870-923 | irritable bowel syndrome | prostate-vesiculitis | probiotic VSL#3 | prostate-vesiculo-epididymitis | rifaximin | chronic bacterial prostatitis

This study was undertaken to evaluate the influence of treatment with rifaximin followed by the probiotic VSL#3 versus no treatment on the progression of chronic prostatitis toward chronic microbial prostate-vesiculitis (PV) or prostate-vesiculo-epididymitis (PVE). A to... View more
Share - Bookmark